Nanosphere Ends Yearly Revenue up on Verigene Sales | GenomeWeb

This article has been updated to include additional Q4 financial information, comments from a conference call, and a stock quote.

NEW YORK (GenomeWeb News) – Nanosphere said on Thursday after the close of the market that its fourth-quarter revenues rose 66 percent, with all of its sales coming from its Verigene System.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.